AHCL vs FERMENTA: Stock Comparison

Anlon Healthcare Limited vs Fermenta Biotech Ltd

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Fermenta Biotech Ltd is the larger company by market capitalisation. Anlon Healthcare Limited shows a higher ROE, faster revenue growth and lower leverage, while Fermenta Biotech Ltd shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Anlon Healthcare Limited and Fermenta Biotech Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, AHCL is more favourable on 8 of 13 scored metrics and FERMENTA on 5These counts are context-free and are not an overall rating.

Key Differences

Market Cap
FERMENTA is the larger company
₹1,272 Cr vs ₹797 Cr
P/E Ratio
FERMENTA has a lower P/E
18.14x vs 27.78x
P/B Ratio
FERMENTA has a lower P/B
3.14x vs 3.46x
EPS
FERMENTA has higher earnings per share
₹24.4 vs ₹0.61
Dividend Yield
FERMENTA has a higher dividend yield
0.62% vs 0%
Revenue Growth (TTM YoY)
AHCL has faster revenue growth
4% vs 0%
EPS Growth (TTM YoY)
FERMENTA has faster EPS growth
0% vs -54.8%
Qtr Sales Growth
AHCL has stronger quarterly sales growth
4.01% vs -13.1%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAHCLFERMENTA
SectorHealthcare
IndustryPharmaceuticals

Price

MetricAHCLFERMENTA
Live Price₹15.01₹432.05
Day Change-0.46%7.74%
Volume28.27 L2.13 L
52-Week High₹161₹479.45
52-Week Low₹12.91₹248.85
Distance from 52W High-90.68%-9.89%

Valuation

MetricAHCLFERMENTA
Market Cap₹797 Cr₹1,272 Cr
P/E Ratio27.78x18.14x
P/B Ratio3.46x3.14x
EPS₹0.61₹24.4
Book Value₹5.11₹138
Dividend Yield0%0.62%

Growth

MetricAHCLFERMENTA
Revenue Growth (TTM YoY)4%0%
EPS Growth (TTM YoY)-54.8%0%
Qtr Sales Growth4.01%-13.1%
Qtr Profit Growth-36.9%-62.9%

Profitability & Leverage

MetricAHCLFERMENTA
ROE18.4%17.4%
ROCE20.8%20.4%
Net Margin22.18%13.37%
Operating Margin27.6%19%
Debt to Equity0.19x0.28x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricAHCLFERMENTA
Promoter Holding52.68%56.47%
FII Holding0.32% 0.09 pp0.02%
DII Holding4.6% 0.11 pp0%
Public Holding42.4% 0.2 pp33.3% 0.69 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Anlon Healthcare Limited and Fermenta Biotech Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.